These programs allow employers to pay employee healthcare claims directly, offering more flexible, customized coverage and improved cost control
GLP-1s help to reduce the impacts of chronic stress and help to alter food reward pathways in positive ways and may help reduce alcohol and other substance use disorders (Mozafarriun et al 2025)
The major issue in this study was the lack of a placebo group to blind the study participants to their treatment allocation

However, it did not yield significant improvements in pain perception.[64] GLP-1 receptors have also been detected in the choroid plexus, and in a rodent model, their activation was shown to reduce cerebrospinal fluid secretion and intracranial pressure (ICP).[65] In patients with idiopathic intracranial hypertension (IIH) and obesity, exenatide, semaglutide, liraglutide have been associated with a reduction in the number of headache days, and exenatide significantly reduced ICP.[66, 67] Furthermore, animal studies have indicated potential benefits of GLP-1RAs in neuropathic pain and diabetic neuropathy, although clinical evidence remains inconsistent.[64] One study reported structural improvements in the nerves of patients with diabetic neuropathy receiving semaglutide or dulaglutide, while two other studies found no significant benefit in neuropathy symptoms with liraglutide and exenatide.[6870] Additional off-label uses under investigation include neurodegenerative disorders, polycystic ovary syndrome (PCOS), and osteoporosis

And limit alcohol and smoking
Miskowiak KW, Carvalho AF, Vieta E, Kessing LV